Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib is effective for severe alopecia areata but has some side effects.

Baricitinib may effectively treat nail changes in alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib can cause excessive hair growth.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.